MHB018A injection

DRUG4 trials

Sponsors

Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Thyroid Eye Disease (TED)Thyroid Eye Disease, TED

Phase 3

MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

RecruitingNCT07257185

Minghui Pharmaceutical (Hangzhou) LtdThyroid Eye Disease (TED)

Start: 2026-03-17End: 2028-08-31Target: 150Updated: 2026-03-30

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

RecruitingNCT07262476

Minghui Pharmaceutical (Hangzhou) LtdThyroid Eye Disease (TED)

Start: 2026-01-09End: 2030-01-31Target: 258Updated: 2026-03-30

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Not yet recruitingNCT07620405

Minghui Pharmaceutical (Hangzhou) LtdThyroid Eye Disease (TED)

Start: 2027-07-01End: 2031-01-01Target: 219Updated: 2026-06-04

Treatment of Chronic Thyroid Eye Disease With MHB018A

Not yet recruitingNCT07622121

Minghui Pharmaceutical (Hangzhou) LtdThyroid Eye Disease, TED

Start: 2026-12-01End: 2029-07-01Target: 135Updated: 2026-06-04